Big Tech Targets Drug Discovery with Wave of Life Science Platforms
AWS, OpenAI, and Anthropic have customized general-purpose assistants into AI-powered workflows for science research, pointing to the growing role of cloud infrastructure and agentic AI in unifying fragmented tools, streamlining data management, and making domain expertise more accessible. The post Big Tech Targets Drug Discovery with Wave of Life Science Platforms appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.